Jean Bousquet to Interleukin-5
This is a "connection" page, showing publications Jean Bousquet has written about Interleukin-5.
Connection Strength
0.187
-
Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma. Respir Med. 2019 04; 150:51-62.
Score: 0.187
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.